Ignite Creation Date:
2024-05-06 @ 10:54 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03386162
Status:
TERMINATED
Last Update Posted:
2022-11-28
First Post:
2017-12-21
Brief Title:
SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer
Sponsor:
UNICANCER
Organization:
UNICANCER
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-18
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-21
First Submit QC Date:
December 21 2017
Study First Post Date:
2017-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-22
Last Update Post Date:
2022-11-28
Last Update Post Date Type:
ACTUAL